TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9589728

Group type: EXPERIMENTAL
Intervention: Temporal approach phacoemulsification combined with separate superior trabeculectomy (Group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard superior phacotrabeculectomy (Group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 50
Study: 8463913

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 176
Study: 4061524

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (600 mg of calcium L-aspartate daily)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nonsupplemented group
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 22
Study: 30529244

Group type: EXPERIMENTAL
Intervention: COPE (Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure)
Number of subjects: 81

Group type: COMPARATOR
Intervention: RP (Relapse Prevention)
Number of subjects: 81
Study: 29878826

Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Computer-based cognitive rehabilitation (CR)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Therapist-directed manualized CR
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Therapist-directed CR integrated with cognitive-behavioral psychotherapy
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Team treatment milieu
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Comorbid depression
Number of subjects: 126
Study: 26475930

Group type: EXPERIMENTAL
Intervention: Heterologous insert regimens
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Heterologous insert groups
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Heterologous vector regimens
Number of subjects: 180
Study: 24839984

Group type: EXPERIMENTAL
Intervention: Silica gel fibre (SGF) in addition to standard treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard-of-care treatment (S-o-C) alone
Number of subjects: 120
Study: 23232109

Group type: EXPERIMENTAL
Intervention: Protocol care (3 weeks)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Usual care (3 weeks)
Number of subjects: 193
Study: 20162747

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 5

Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 5
Study: 17285423

Group type: EXPERIMENTAL
Intervention: MgSO(4) 40 mg.kg(‐1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 22
Study: 15642806

Group type: EXPERIMENTAL
Intervention: Vision therapy/orthoptics
Number of subjects: 47

Group type: COMPARATOR
Intervention: Pencil push-ups
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo vision therapy/orthoptics
Number of subjects: 47
Study: 12119223

Group type: EXPERIMENTAL
Intervention: GM-CSF (3 mcg/kg intravenous daily for 5 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10466241

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (letrozole, anastrazole)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LH-RH agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy regimens (CMF or CAF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taxanes (paclitaxel and docetaxel)
Number of subjects: 0
Study: 7473906

Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg via enteral route
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fluconazole 100 mg via intravenous (IV) route
Number of subjects: 18
Study: 2258807

Group type: EXPERIMENTAL
Intervention: Topical nonsteroidal anti-inflammatory agent (0.03% flurbiprofen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical steroid (1% prednisolone acetate)
Number of subjects: 0
Study: 7029684

Group type: EXPERIMENTAL
Intervention: Razoxane (125 mg twice daily for 5 consecutive days every week indefinitely)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control (usual clinical care without razoxane)
Number of subjects: 162
Study: 31532235

Group type: EXPERIMENTAL
Intervention: Balance training exergame
Number of subjects: 22
Study: 31666825

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 456
Study: 28045551

Group type: EXPERIMENTAL
Intervention: Low-literacy asthma action plan
Number of subjects: 217

Group type: COMPARATOR
Intervention: Standard asthma action plan
Number of subjects: 217
Study: 27140802

Group type: EXPERIMENTAL
Intervention: Separate-tablet regimen (EVG 150mg + COBI 150mg + FTC/TDF 200mg/300mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-tablet regimen (EVG/COBI/FTC/TDF)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 24
Study: 23632659

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.45 mg
Number of subjects: 3397

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.625 mg
Number of subjects: 3397

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3397

Group type: EXPERIMENTAL
Intervention: BZA/CE treatment
Number of subjects: 3397

Group type: EXPERIMENTAL
Intervention: Hot flush score reduction at week 12
Number of subjects: 3397
Study: 21558036

Group type: EXPERIMENTAL
Intervention: CT fluoroscopy guidance
Number of subjects: 116

Group type: COMPARATOR
Intervention: C-arm fluoroscopy guidance
Number of subjects: 116
Study: 19475630

Group type: EXPERIMENTAL
Intervention: 0.5 mg oral mecamylamine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.2 mg oral mecamylamine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1.0 mg oral mecamylamine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 19025429

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day with prasugrel (60 mg loading dose followed by 10 mg/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day with clopidogrel (300 mg loading dose followed by 75 mg/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day with prasugrel or clopidogrel
Number of subjects: 69

Group type: COMPARATOR
Intervention: Atorvastatin 80 mg/day
Number of subjects: 69
Study: 16557033

Group type: EXPERIMENTAL
Intervention: Plasma samples from improvers with declining cytokine levels over time
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Plasma samples from nonimprovers with sustained elevation in cytokine levels over time
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Lung tissues of patients with severe ARDS
Number of subjects: 3
Study: 12122218

Group type: EXPERIMENTAL
Intervention: Occluded vision during the first movement (Experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Occluded vision during the second movement (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One-target advantage when the second movement was in the same direction as the first
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One-target advantage when the second movement was reversed with respect to the home button
Number of subjects: 0
Study: 10432470

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low dose methylphenidate (0.28 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High dose methylphenidate (0.56 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline (off drug)
Number of subjects: 20
Study: 8853523

Group type: EXPERIMENTAL
Intervention: New anti-cancer agents in phase II studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: New anti-cancer agents in phase III studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New anti-cancer agents in phase IV studies
Number of subjects: 0
Study: 2277378

Group type: EXPERIMENTAL
Intervention: cefmetazole
Number of subjects: 145

Group type: COMPARATOR
Intervention: cefoxitin
Number of subjects: 145
Study: 6990475

Group type: EXPERIMENTAL
Intervention: 14-valent pneumococcal capsular polysaccharide vaccine (Pn)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Haemophilus influenzae type b capsular polysaccharide vaccine (Hib)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 313
Study: 29562806

Group type: EXPERIMENTAL
Intervention: Calcitriol therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 27355577

Group type: EXPERIMENTAL
Intervention: Repetitive transorbital alternating current stimulation (rtACS) for 50 min daily for 10 days
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sham-stimulation for 50 min daily for 10 days
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Repetitive transorbital alternating current stimulation (rtACS)
Number of subjects: 82
Study: 24374518

Group type: EXPERIMENTAL
Intervention: Self-gripping Progrip mesh
Number of subjects: 1353

Group type: COMPARATOR
Intervention: Conventional suture-fixed Lichtenstein technique
Number of subjects: 1353
Study: 22349778

Group type: EXPERIMENTAL
Intervention: TPB-based email messages (low frequency)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: TPB-based email messages (high frequency)
Number of subjects: 194
Study: 20395940

Group type: EXPERIMENTAL
Intervention: L-NMMA infusion after ischemia at wrist level for 1 minute
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: L-NMMA infusion after ischemia at wrist level for 2 minutes
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: L-NMMA infusion after ischemia at wrist level for 5 minutes
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline infusion after ischemia at upper arm
Number of subjects: 28
Study: 19099330

Group type: COMPARATOR
Intervention: Normoxic condition (20.93% O2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hypoxic condition (14% O2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hypoxic condition (12% O2)
Number of subjects: 12
Study: 16337144

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 101

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 101
Study: 12681862

Group type: EXPERIMENTAL
Intervention: Ultrasound scan at 30-32 weeks' and 36-37 weeks' gestation
Number of subjects: 1998

Group type: COMPARATOR
Intervention: Control group receiving standard antenatal care
Number of subjects: 1998
Study: 10408999

Group type: EXPERIMENTAL
Intervention: Awareness group (received specific informational brochures on diet and cardiovascular risk factors and the reasons for the treatment)
Number of subjects: 3845

Group type: COMPARATOR
Intervention: Control group (received the information normally given by the practitioners)
Number of subjects: 3845

Group type: EXPERIMENTAL
Intervention: Noncompliant patients
Number of subjects: 3845
Study: 8726532

Group type: EXPERIMENTAL
Intervention: Noun-related maps
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verb-related maps
Number of subjects: 0
Study: 1932649

Group type: EXPERIMENTAL
Intervention: Bovine lung heparin (BLH)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Porcine mucosal heparin (PMH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 7333749

Group type: COMPARATOR
Intervention: High blood glucose (G)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High blood free fatty acid (F)
Number of subjects: 9
Study: 31093835

Group type: EXPERIMENTAL
Intervention: Nurse-led telephone follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-initiated follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine hospital-based follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital-based follow-up
Number of subjects: 0
Study: 28279705

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 24947656

Group type: EXPERIMENTAL
Intervention: Normal colposcopy examination with follow-up cervical cytology every 6 months for 3 years.
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Women with initial mild dyskaryosis who were HrHPV-positive.
Number of subjects: 884
Study: 24036618

Group type: EXPERIMENTAL
Intervention: Diabetic nephropathy (DN) patients
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: CKD without diabetes
Number of subjects: 79

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 79
Study: 21358291

Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP6) acupuncture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Xuanzhong (GB39) control group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonacupoint control group
Number of subjects: 40

Group type: COMPARATOR
Intervention: No acupuncture group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All acupuncture groups (SP6, GB39, nonacupoint)
Number of subjects: 40
Study: 18972125

Group type: EXPERIMENTAL
Intervention: Skin protection and skin care in combination
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Skin care alone
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Skin protection alone
Number of subjects: 485

Group type: COMPARATOR
Intervention: Control group (only cleansing)
Number of subjects: 485
Study: 17060516

Group type: EXPERIMENTAL
Intervention: 2.0-g extended-release azithromycin microspheres (single-dose regimen)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 500-mg immediate-release azithromycin tablet (3-day regimen)
Number of subjects: 24
Study: 14962523

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg twice daily
Number of subjects: 108

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: rosiglitazone
Number of subjects: 108
Study: 11684346

Group type: EXPERIMENTAL
Intervention: Ischemic stroke patients
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Patients not taking aspirin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Patients taking aspirin
Number of subjects: 25
Study: 9559631

Group type: COMPARATOR
Intervention: Neomycin and erythromycin (Group 1)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Neomycin and metronidazole (Group 2)
Number of subjects: 82
Study: 7929019

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 19

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 19
Study: 2907898

Group type: EXPERIMENTAL
Intervention: Protocol I: 7 injections of 1,500 IU hCG every other day
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Protocol II: 4 injections of 100 IU/kg hCG at 4- to 5-day intervals
Number of subjects: 183
Study: 31021691

Group type: EXPERIMENTAL
Intervention: Thoracic spine manipulation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 43
Study: 28360187

Group type: EXPERIMENTAL
Intervention: FGR children
Number of subjects: 96
Study: 24748286

Group type: EXPERIMENTAL
Intervention: Intra-articular PRP injections (3 injections at monthly intervals)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Intra-articular PRP injections (2 cycles of 3 injections)
Number of subjects: 93
Study: 23899048

Group type: EXPERIMENTAL
Intervention: Task-oriented training with trunk restraint
Number of subjects: 16

Group type: COMPARATOR
Intervention: Task-oriented training without trunk restraint
Number of subjects: 16
Study: 21576281

Group type: EXPERIMENTAL
Intervention: Supervised exercise‐based lifestyle intervention (initial gym‐based program and lifestyle and diet advice followed by telephone‐guided supervision)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Supervised exercise‐based lifestyle intervention
Number of subjects: 223
Study: 19619607

Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal tDCS of the left DLPFC)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 27
Study: 16490513

Group type: EXPERIMENTAL
Intervention: Ibopamine 2% solution administered as eyedrops
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo eyedrop
Number of subjects: 10
Study: 15016484

Group type: EXPERIMENTAL
Intervention: Cell infusion
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: G-CSF alone
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study: 11735095

Group type: EXPERIMENTAL
Intervention: Fasting homocysteine (tHcy) levels
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Homocysteine levels 4 hours after methionine load
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Prevalence of hyperhomocysteinemia
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Association with concurrent diseases
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Multiple stepwise regression analysis
Number of subjects: 600
Study: 9207407

Group type: EXPERIMENTAL
Intervention: Daunorubicin (DR)
Number of subjects: 1419

Group type: COMPARATOR
Intervention: No Daunorubicin (no DR)
Number of subjects: 1419
Study: 8188884

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Dodecyl trimethyl ammonium bromide (DTAB)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Potassium soap
Number of subjects: 11
Study: 3311687

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg) and Pirenzepine (50 mg) at bed-time
Number of subjects: 129

Group type: COMPARATOR
Intervention: Cimetidine (800 mg) and Placebo at bed-time
Number of subjects: 129
Study: 29353535

Group type: EXPERIMENTAL
Intervention: Alternate-day fasting (ADF)
Number of subjects: 34
Study: 27385430

Group type: EXPERIMENTAL
Intervention: Medication organisation devices (MODs) supplied either weekly or monthly
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Medication organisation devices (MODs)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: MOD monthly
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: MODs
Number of subjects: 147
Study: 24423928

Group type: EXPERIMENTAL
Intervention: Rapid genetic counselling and testing (RGCT)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: DNA test results before surgery (within RGCT group)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 265
Study: 23532993

Group type: EXPERIMENTAL
Intervention: Behaviorally focused maintenance treatment (MT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Socially focused maintenance treatment (MT)
Number of subjects: 101
Study: 20093826

Group type: EXPERIMENTAL
Intervention: Citrate anticoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin anticoagulation
Number of subjects: 0
Study: 19064606

Group type: EXPERIMENTAL
Intervention: Algorithm for diagnosis of active labour
Number of subjects: 4503

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 4503
Study: 16914460

Group type: EXPERIMENTAL
Intervention: DEX-0.2
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: DEX-0.4
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 12835242

Group type: EXPERIMENTAL
Intervention: Caribbean origin
Number of subjects: 708

Group type: COMPARATOR
Intervention: British White origin
Number of subjects: 708
Study: 11168739

Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD) 20 mg 2x daily for 12 weeks
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD) 20 mg 1x daily in part III
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 75
Study: 9760806

Group type: EXPERIMENTAL
Intervention: Allele I of the ACE gene
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Allele D of the ACE gene
Number of subjects: 128

Group type: COMPARATOR
Intervention: Normotensives and borderline to mild hypertensives
Number of subjects: 128
Study: 8141188

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol exposure
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control (unexposed)
Number of subjects: 198
Study: 2448190

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Methotrexate (MTX) with citrovorum factor
Number of subjects: 21

Group type: COMPARATOR
Intervention: Spontaneous decline post-evacuation
Number of subjects: 21
Study: 31795755

Group type: EXPERIMENTAL
Intervention: Covariate presumed as random
Number of subjects: 0

Group type: COMPARATOR
Intervention: Covariate presumed as fixed
Number of subjects: 0
Study: 30026230

Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression (ASD)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Diagnostic arthroscopy (placebo control)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 210
Study: 28499257

Group type: EXPERIMENTAL
Intervention: Standardised mindfulness technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mindfulness-based interventions
Number of subjects: 0
Study: 26230671

Group type: EXPERIMENTAL
Intervention: 300 mg/day intranasal glutathione
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 600 mg/day intranasal glutathione
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study: 24124993

Group type: EXPERIMENTAL
Intervention: Modified constraint-induced movement therapy (CIMT at home)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional physical and occupational therapy (therapy as usual)
Number of subjects: 144
Study: 21923696

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18539527

Group type: EXPERIMENTAL
Intervention: Mobile phone-based Advanced Symptom Management System (ASyMS©)
Number of subjects: 35
Study: 17157113

Group type: EXPERIMENTAL
Intervention: Insulin detemir morning injection
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Insulin detemir evening injection
Number of subjects: 504

Group type: COMPARATOR
Intervention: NPH evening injection
Number of subjects: 504
Study: 14616819

Group type: EXPERIMENTAL
Intervention: UVA-1 irradiation (40 J/cm2)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28